Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Hepatocellular Carcinoma
52%
Hepatitis C Virus
50%
Liver
38%
Liver Transplantation
37%
Immune Regulation
28%
Hepatitis C Virus Infection
28%
Laparoscopic Sleeve Gastrectomy
24%
Colitis
23%
Nonalcoholic Steatohepatitis
22%
Odds Ratio
22%
Lymphocytes
20%
Inflammatory Bowel Disease
19%
Extractable Protein
19%
Transplantation
19%
Hepatitis C
17%
Fibrosis
17%
Cirrhosis
17%
Primary Sclerosing Cholangitis
17%
Liver Fibrosis
16%
Israel
16%
Serum Levels
16%
New Onset
14%
CD4+
13%
Crohn's Disease
13%
COVID-19
13%
Amiodarone
13%
Adoptive Transfer
13%
Liver Damage
13%
Experimental Colitis
13%
Insulin Resistance
12%
Elevated Alanine Aminotransferase
12%
Endoplasmic Reticulum Stress (ER stress)
12%
Liver Disease
12%
Risk Factors
12%
Microbiome
12%
Intraductal Papillary mucinous Neoplasm
11%
Kidney Transplant Recipients
11%
Phase I Clinical Trial
11%
Transarterial Chemoembolization
11%
Opioid Agonist Treatment
11%
Humoral Response
11%
Primary Biliary Cholangitis
11%
Biliary Epithelial Cells
11%
Hepatitis B Surface Antigen (HBsAg)
11%
Ribavirin
11%
Body Mass Index
11%
Obesity
11%
Metabolic Syndrome
10%
NK1.1
10%
Medicine and Dentistry
Nonalcoholic Fatty Liver
65%
Hepatocellular Carcinoma
48%
Hepatitis C Virus
41%
Liver Transplantation
34%
Fibrosis
26%
Hepatitis C
25%
Colitis
24%
Prevalence
23%
Infection
21%
Liver Cirrhosis
18%
Liver Disease
18%
Fatty Liver
17%
Diseases
17%
Natural Killer T Cell
16%
Hepatitis B Virus
16%
Neoplasm
16%
Lymphocyte
16%
Liver Injury
15%
Body Mass Index
14%
Inflammatory Bowel Disease
14%
Liver Fibrosis
13%
Laparoscopic Sleeve Gastrectomy
13%
Epithelial Cell
13%
Clinical Trial
12%
Experimental Colitis
12%
Adoptive Transfer
12%
Intraductal Papillary Mucinous Tumor
12%
Prospective Study
12%
Odds Ratio
12%
Ribavirin
11%
Colorectal Adenoma
11%
Steatohepatitis
11%
Chronic Hepatitis C
11%
Transcatheter Arterial Chemoembolization
11%
Humoral Immunity
11%
Kidney Graft
11%
CD8 Antigen
11%
Adverse Event
11%
Bloodstream Infection
10%
Pancreas Islet Cell Tumor
10%
Hepatocyte
10%
Immunoregulation
10%
Immunosuppressive Treatment
9%
Hepatitis C Virus Genotype 1
9%
Non-Alcoholic Fatty Liver Disease
9%
Antivirus Agent
9%
Public Health
9%
Primary Sclerosing Cholangitis
8%
Microbiome
8%
Crohn's Disease
8%
